GlassScriptPhysician profile
David G Song
NPI 1699115972
$4,471.38
in general payments reported to CMS, 2019-2025
33 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $243 · 2021: $385 · 2022: $885 · 2023: $693 · 2024: $903 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972 · Education: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,972.44 |
| Education | $310.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,400.76 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Pfizer INC. | $570.77 | 2019-2025 | |
| 180 Medical, INC. | $318.24 | 2021-2025 | |
| Laborie Medical Technologies Corp. | $296.33 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $272.37 | 2019-2025 | Erleada, Balversa, Akeega |
| Boston Scientific Corporation | $271.71 | 2020-2024 | Rezum Generator, Advance Xp |
| Endo Pharmaceuticals INC. | $228.28 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $177.68 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Scientific Affairs, LLC | $115.03 | 2025 | Erleada |
| Convatec INC. | $74.29 | 2022-2025 | |
| Abc Home Medical Supply, INC. | $70.37 | 2022 | |
| Hollister Incorporated | $56.97 | 2022-2023 | Vapro, Onli, Infyna Chic |
| Abbvie INC. | $56.06 | 2023-2024 | Lupron Depot |
| Seagen INC. | $54.99 | 2025 | |
| Procept Biorobotics Corporation | $53.32 | 2023-2025 | Aquabeam Robotic System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $50.25 | 2019-2024 | Jynarque |
| Blue Earth Diagnostics | $44.40 | 2019-2021 | |
| Immunitybio, INC. | $42.56 | 2024-2025 | |
| Esperion Therapeutics, INC. | $42.34 | 2024 | Nexletol |
| Urogen Pharma, INC. | $36.60 | 2025 | |
| Tolmar, INC. | $23.87 | 2024 | |
| Medline Industries LP | $22.63 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $22.56 | 2024 | Bard Urinary Drainage Bag |
| Tolmar Pharmaceuticals, INC. | $22.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.83 | 2022 | |
| Sagent Pharmaceuticals | $20.00 | 2024 | Glydo |
| Teleflex LLC | $17.89 | 2024 | Urolift |
| Coloplast Corp | $16.96 | 2020 | |
| Rochester Medical Corporation | $16.40 | 2021 | |
| Srs Medical Systems, INC. | $14.74 | 2022 | |
| Endo USA, INC. | $14.39 | 2025 | Xiaflex, Aveed |
| Acerus Pharmaceuticals Corporation | $12.70 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.